A Study on Vonoprazan in the Real-world Clinical Practice in China
NCT04501627 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2023-10-25
Summary
The purpose of this study is to evaluate the safety of Vonoprazan by assessing all adverse events (AEs), serious adverse events (SAEs), and adverse drug reactions (ADRs) in routine clinical settings in China.
Conditions
- Esophagitis Peptic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-24
- Primary Completion
- 2023-06-27
- Completion
- 2023-06-27
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
NCT04799158 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation
NCT03116841 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population
NCT00516971 ·Status: UNKNOWN ·Phase: NA
-
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
NCT03214081 ·Status: COMPLETED
-
Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis
NCT06720610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks
NCT03591653 ·Status: COMPLETED ·Phase: PHASE3
-
The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole
NCT04720781 ·Status: COMPLETED ·Phase: NA
-
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
NCT06851559 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT05195528 ·Status: COMPLETED ·Phase: PHASE3
-
The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department
NCT02506634 ·Status: COMPLETED
-
Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.
NCT02606851 ·Status: COMPLETED
-
Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis
NCT01452776 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers
NCT01705275 ·Status: COMPLETED ·Phase: PHASE1
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
NCT05055128 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
NCT06106022 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
NCT00175045 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
NCT04028466 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis
NCT02873702 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
NCT05343364 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
NCT03214952 ·Status: COMPLETED
-
Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment
NCT06348420 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
NCT04531475 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA